Company intelligence / Profile preview

Prange Pharma

Plettenberg, North Rhine-Westphalia, Germanyprange-pharma.de ↗

Ownership: Private
Employees: ~400
Development stage: Commercial

Overview

Prange Pharma operates as a pharmaceutical holding within the family-owned Prange Group. It provides contract manufacturing and development services for human medicines—especially in dermatology, urology, oral contraceptives—and animal health supplements. The group has a global presence with operations in Germany, France, Japan, USA and recently expanded sterile liquid manufacturing capabilities through acquisitions. In 2019 its companies generated over €50 million revenue with about 400 employees at six locations worldwide[3][4].

Therapeutic areas: OtherWomen's HealthDermatologyMen's Health
Modalities: Small moleculeBiologic
Industry: Contract Manufacturing Organization

Partnerships

Adragos PharmaFresenius Kabi’s Halden site acquisition

Beyond the preview

Go deeper on Prange Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prange Pharma.

Explore the full profile